Identifying drugs that regulate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) infection and its symptoms has been a pressing area of investigation during the …

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is the cause of the novel
coronavirus disease 2019 (COVID‐19), a highly pathogenic and sometimes fatal respiratory …

Early in the COVID-19 pandemic, anecdotal reports emerged suggesting non-steroidal anti-
inflammatory drugs (NSAIDs) may increase susceptibility to infection and adversely impact …

Coronavirus disease 2019 (COVID-19) infection causes acute lung injury, resulting from
aggressive inflammation initiated by viral replication. There has been much speculation …

Taking anti-inflammatory drugs, including non-steroidal (NSAIDs), during Covid-19 infection,
how much is risky? The French Minister of Health, who has raised an alarm on a possible …

Abstract The coronavirus disease 19 (COVID-19) pandemic is currently the most acute
healthcare challenge in the world. Despite growing knowledge of the nature of Severe Acute …

Non-steroidal anti-inflammatory drugs (NSAIDs) have an optional prescription status that
has resulted in frequent use, in particular for the symptomatic treatment of fever and non …

Abstract The World Health Organization has described the 2019 Coronavirus disease
caused by an influenza-like virus called SARS-CoV-2 as a pandemic. Millions of people …

Concern about the appropriate role of nonsteroidal anti-inflammatory drugs (NSAIDs) in
COVID-19 speculate that NSAIDs, in particular ibuprofen, may upregulate the entry point for …

In December 2019, a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
started spreading worldwide causing the coronavirus disease 2019 (COVID-19) pandemic …